Enchondroma: A Benign Osseous Lesion with High F-18 FDG Uptake

Clinical Nuclear Medicine

Volumn 27, Issue 10, 2002, Pages 695-697

  Döbert, Natascha ^a   Menzel, Christian ^a   Ludwig, Ralf ^a   Berner, Uwe ^a   Diehl, Michaela ^a   Hamscho, Nadja ^a   Grünwald, Frank ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Diagnostic Pitfalls; Enchondroma; Positron Emission Tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; HYALIN; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BENIGN TUMOR; BONE RADIOGRAPHY; BONE RESECTION; CANCER SCINTISCANNING; CANCER STAGING; CASE REPORT; CELL PROLIFERATION; CHONDROSARCOMA; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG UPTAKE; ENCHONDROMA; FEMALE; FEMUR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MELANOMA; METAPHYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; TREATMENT OUTCOME; WHOLE BODY SCINTISCANNING; CHONDROMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CYTOLOGY; FEMUR TUMOR; METABOLISM; PATHOLOGY; SCINTISCANNING; SECOND CANCER; SKIN TUMOR; WHOLE BODY COUNTING;

ADULT; CHONDROMA; CHONDROSARCOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEMORAL NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; HYALIN; MELANOMA; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; RADIOPHARMACEUTICALS; SKIN NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; WHOLE-BODY COUNTING;

EID: 0036778383     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200210000-00001     Document Type: Article

References (7)

1. Reske SN, Kotzerke J: FDG-PET for clinical use. Eur J Nucl Med 28:1707, 2001.
2. Dimitrakopoulou-Strauss A, Strauss LG, Heichel T, et al: The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions. J Nucl Med 43:510, 2002.
3. Zhuang H, Alavi A: 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 32:47, 2002.
4. Schulte M, Brecht-Krauss D, Heymer B, et al: Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med 41:1695, 2000.
5. Kern KA, Brunetti A, Norton JA, et al: Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med 29:181, 1988.
6. Adams S, Baum RP, Hertel A, et al: Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings. Eur J Nucl Med 25:1277, 1998.
7. Kobayashi H, Kotoura Y, Hosono M, et al: Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy. Clin Nucl Med 20:361, 1995.